Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1fgi | SU1 | Fibroblast growth factor receptor 1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1fgi | SU1 | Fibroblast growth factor receptor 1 | / | 1.000 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.493 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.489 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.474 | |
| 4elf | 35I | Dihydrofolate reductase | / | 0.467 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.463 | |
| 3w2c | N15 | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.459 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.459 | |
| 4jlk | 1NO | Deoxycytidine kinase | 2.7.1.74 | 0.458 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.458 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 3zei | AWH | O-acetylserine sulfhydrylase | / | 0.456 | |
| 4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.456 | |
| 1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.454 | |
| 4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.452 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.452 | |
| 4at3 | LTI | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.452 | |
| 2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.451 | |
| 4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.449 | |
| 3d5f | L41 | Peroxisome proliferator-activated receptor delta | / | 0.448 | |
| 3jzm | ATP | Circadian clock protein kinase KaiC | 2.7.11.1 | 0.448 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.448 | |
| 3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.447 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.446 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.446 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 3k0f | ATP | Circadian clock protein kinase KaiC | 2.7.11.1 | 0.445 | |
| 3mla | JJZ | Probable nicotinate-nucleotide adenylyltransferase | / | 0.445 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.445 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.444 | |
| 3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.444 | |
| 4bbh | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.444 | |
| 1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 1tf7 | ATP | Circadian clock protein kinase KaiC | 2.7.11.1 | 0.443 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
| 4iae | 1DX | Alr2278 protein | / | 0.443 | |
| 4phl | PIL | Phosphodiesterase | / | 0.443 | |
| 2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.442 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.442 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.442 | |
| 1u9i | ATP | Circadian clock protein kinase KaiC | 2.7.11.1 | 0.441 | |
| 2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3aba | FLI | Cytochrome P450 | / | 0.441 | |
| 1gqt | ACP | Ribokinase | / | 0.440 | |
| 4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.440 |